» Articles » PMID: 32667590

The Role of the Microbiota-gut-brain Axis in Neuropsychiatric Disorders

Overview
Specialty Psychiatry
Date 2020 Jul 16
PMID 32667590
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The microbiota-gut-brain axis is a bidirectional signaling mechanism between the gastrointestinal tract and the central nervous system. The complexity of the intestinal ecosystem is extraordinary; it comprises more than 100 trillion microbial cells that inhabit the small and large intestine, and this interaction between microbiota and intestinal epithelium can cause physiological changes in the brain and influence mood and behavior. Currently, there has been an emphasis on how such interactions affect mental health. Evidence indicates that intestinal microbiota are involved in neurological and psychiatric disorders. This review covers evidence for the influence of gut microbiota on the brain and behavior in Alzheimer disease, dementia, anxiety, autism spectrum disorder, bipolar disorder, major depressive disorder, Parkinson's disease, and schizophrenia. The primary focus is on the pathways involved in intestinal metabolites of microbial origin, including short-chain fatty acids, tryptophan metabolites, and bacterial components that can activate the host's immune system. We also list clinical evidence regarding prebiotics, probiotics, and fecal microbiota transplantation as adjuvant therapies for neuropsychiatric disorders.

Citing Articles

Sexual dimorphism in immunity and longevity among the oldest old.

Arakelyan N, Kupriyanova D, Vasilevska J, Rogaev E Front Immunol. 2025; 16:1525948.

PMID: 40034689 PMC: 11872714. DOI: 10.3389/fimmu.2025.1525948.


Harnessing Gut Microbiota for Biomimetic Innovations in Health and Biotechnology.

Beltran-Velasco A, Clemente-Suarez V Biomimetics (Basel). 2025; 10(2).

PMID: 39997096 PMC: 11852373. DOI: 10.3390/biomimetics10020073.


Potential common targets of music therapy intervention in neuropsychiatric disorders: the prefrontal cortex-hippocampus -amygdala circuit (a review).

Dan Y, Xiong Y, Xu D, Wang Y, Yin M, Sun P Front Hum Neurosci. 2025; 19:1471433.

PMID: 39963392 PMC: 11832007. DOI: 10.3389/fnhum.2025.1471433.


BB05 alleviates depressive symptoms in mice via the AKT/mTOR pathway.

Pan Y, Huang Q, Liang Y, Xie Y, Tan F, Long X Front Nutr. 2025; 12:1529566.

PMID: 39949541 PMC: 11821494. DOI: 10.3389/fnut.2025.1529566.


Anxiety disorders and the gut microbiota: a bibliometric and visual analysis.

Guo L, Ding Q, Li Q, Zheng D, Guo L, Cao X Front Psychiatry. 2025; 15:1517508.

PMID: 39902242 PMC: 11788897. DOI: 10.3389/fpsyt.2024.1517508.


References
1.
Tankou S, Regev K, Healy B, Cox L, Tjon E, Kivisakk P . Investigation of probiotics in multiple sclerosis. Mult Scler. 2018; 24(1):58-63. DOI: 10.1177/1352458517737390. View

2.
Kang D, Adams J, Gregory A, Borody T, Chittick L, Fasano A . Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017; 5(1):10. PMC: 5264285. DOI: 10.1186/s40168-016-0225-7. View

3.
Baxter N, Schmidt A, Venkataraman A, Kim K, Waldron C, Schmidt T . Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers. mBio. 2019; 10(1). PMC: 6355990. DOI: 10.1128/mBio.02566-18. View

4.
Gao J, Xu K, Liu H, Liu G, Bai M, Peng C . Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism. Front Cell Infect Microbiol. 2018; 8:13. PMC: 5808205. DOI: 10.3389/fcimb.2018.00013. View

5.
Fischer A, Sananbenesi F, Wang X, Dobbin M, Tsai L . Recovery of learning and memory is associated with chromatin remodelling. Nature. 2007; 447(7141):178-82. DOI: 10.1038/nature05772. View